John Townsend
2020
In 2020, John Townsend earned a total compensation of $39.8K as Chief Financial Officer at Unicycive Therapeutics.
Compensation breakdown
| Other | $39,750 |
|---|---|
| Total | $39,750 |
Townsend received $39.8K in other compensation, accounting for 100% of the total pay in 2020.
Rankings
In 2020, John Townsend's compensation ranked 12,997th out of 13,090 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,997 out of 13,090 | 1st |
Division Manufacturing | 5,589 out of 5,624 | 1st |
Major group Chemicals And Allied Products | 2,243 out of 2,257 | 1st |
Industry group Drugs | 1,946 out of 1,957 | 1st |
Industry Pharmaceutical Preparations | 1,454 out of 1,462 | 1st |
Source: SEC filing on April 19, 2022.
Townsend's colleagues
We found two more compensation records of executives who worked with John Townsend at Unicycive Therapeutics in 2020.